HAL vs PALI · P/E 9.3, $19.05B cap vs P/E 15, $316.3M cap
Halliburton Company (HAL) versus Palisade Bio Inc (PALI) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported PALI revenue for 2024-12-31 was $0. Net income was -$14.4M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
Not investment advice. Open the HAL and PALI stock pages for the full models.
Not investment advice.